Healthtech Startups

Love With Food operated a subscription service that shipped monthly boxes of snack samples to consumers. The assortments emphasized all-natural, organic, and gluten-free items, letting subscribers sample products in small portions before buying full-size packages, with free delivery and no cancellation fee.

3 investors

Lovon is an AI-powered voice-based therapist that provides on-demand emotional and relationship support through phone calls, designed as a supplement to traditional therapy rather than a replacement. The service helps individuals and couples process stress, navigate conflicts, and build healthier relationships using evidence-based clinical methods.

3 investors

Lumary develops ABA practice management software for autism therapy providers in the US and disability, aged care, and allied health providers in Australia, helping them manage operations and outcome-based care delivery. The platform is used by healthcare provider organizations to process claims and support patient services.

3 investors

Lumere, part of GHX, provides clinically integrated supply chain and value analysis tools that help healthcare providers reduce costs and variation through evidence-based product decisions and analytics. Its offering supports supply chain and clinical teams in hospitals with strategic sourcing, new product review workflows, and savings tracking.

3 investors

Luminoma is developing the LumAssure, a portable diagnostic-aid that uses Raman spectroscopy to non-invasively assess whether a skin lesion is likely malignant or benign within seconds. The device is intended to help clinicians make more objective skin cancer biopsy decisions and reduce unnecessary biopsies.

3 investors

Lumira Ventures is a venture capital firm that invests in biotherapeutic and medical device companies developing innovative therapeutic solutions for patients. The firm focuses on companies creating disruptive treatments, addressing unmet medical needs, improving outcomes, and reducing healthcare costs.

3 investors

Lumitron Technologies develops laser-Compton light sources that produce monochromatic x-ray and gamma-ray outputs for ultrahigh-fidelity imaging, ultra-low dose radiography, and precision radiotherapy. Its technology targets medical applications such as FLASH radiotherapy and k-edge subtraction imaging, as well as element- and isotope-specific material identification.

3 investors

Lumosity offers a brain-training program that adapts lab-based cognitive tasks into games, providing users with progress tracking, feedback, and insights into their cognition. The program adjusts to each user's age, skill level, and cognitive strengths and weaknesses.

3 investors

Luna develops a small patch pump with automated insulin dosing for insulin pen users to help manage glucose levels overnight. The device uses a closed-loop algorithm to adjust insulin doses automatically while users sleep.

3 investors

Lupeng Pharmaceutical develops next-generation small-molecule targeted drugs for malignant tumors and autoimmune diseases, focusing on hematologic cancer targets such as BTK, Bcl-2, and Bcl-xL, with multi-center clinical development and commercialization in international and Chinese markets. Its lead drug rocbrutinib (Lukeda) has received NMPA approval for market in China.

3 investors

Lutris Pharma develops targeted skin protection treatments for cancer patients, combining clinicians and scientists with oncology expertise. The company focuses on pharmaceutical development in the oncology and dermatology space.

3 investors

Luxsonic Healthcare develops enterprise imaging and clinical simulation software for health systems, including a unified imaging platform with web workflows, VR reading environments, and cloud-native PACS, plus immersive VR simulation for medical education and training. It serves clinicians, residents, and medical institutions across North America.

3 investors

Lyell develops CAR T-cell therapies for cancer patients by leveraging deep expertise in T-cell biology and oncology. The company operates an integrated pipeline spanning discovery through manufacturing and clinical trials, with its own manufacturing facility in Washington.

3 investors

Lynk Pharma develops pharmaceutical products for rheumatoid arthritis and ankylosing spondylitis, with selective licensing arrangements for regional commercialization.

3 investors

M7 Health builds an AI-powered nurse and staff scheduling platform that forecasts staffing demand, auto-balances schedules, fills open shifts, and provides real-time coverage visibility for hospitals and health systems. It serves frontline nurses, managers, house supervisors, and central staffing offices across organizations ranging from rural community hospitals to large academic medical centers.

3 investors

Mable is a genomics-based telehealth platform that provides personalized migraine care by analyzing patients' genetic and biomarker data to inform individualized treatment plans. The company serves migraine sufferers seeking precision medicine alternatives to traditional trial-and-error medication approaches.

3 investors

MAGENTIQ-EYE develops an AI-assisted system for detecting gastrointestinal lesions during colonoscopies, with validation from a multinational clinical trial. The company serves gastroenterologists and healthcare providers seeking to improve colorectal cancer detection and prevention.

3 investors

Magnamed appears to offer medical equipment such as transport and ICU ventilators and analyzers for healthcare professionals, based on its navigation categories. The page provides no further detail about the products or company.

3 investors

Magnetic Particle Imaging (MPI) is an imaging technology that detects iron oxide nanoparticle tracers using time-varying magnetic fields to create medical images with high contrast and sensitivity. The company develops this emerging imaging modality for medical imaging and in vivo translational research applications.

3 investors

Mama Health is a platform connecting people living with chronic and rare conditions to share experiences and learn from others, while providing direct patient insights to the life sciences industry for research and treatment development.

3 investors

Mango Micro makes the M6, an automated microbial colony counting system that uses machine learning to deliver CFU counts and digitize quality-control labs. It targets regulated manufacturing environments with features like 21 CFR Part 11 compliance, LIMS integration, and non-destructive testing across six hot-swappable test bays.

3 investors

Mango Health develops an AI-powered tool that guides users through exposure and response prevention (ERP) therapy for obsessive-compulsive disorder, offering continuous support and educational content as an alternative to traditional clinical treatment.

3 investors

Mango Sciences works with healthcare providers in emerging markets to collect and analyze clinical patient data from underrepresented populations, building a base of real-world evidence and global health data. Its data analytics platform, paired with a patient affordability and accessibility initiative, aims to generate healthcare insights that improve patient access and care.

3 investors

Manual is a UK-based men's health platform offering prescription treatments, custom formulations, ongoing medical support, digital progress tracking, and at-home diagnostic blood tests. It operates a subscription model with licensed medication and next-day delivery for men's wellness and healthcare.

3 investors